Spark Therapeutics (ONCE) Short Interest Ratio & Short Volume → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ONCE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisHeadlinesSocial MediaStock AnalysisHeadlinesSocial Media Spark Therapeutics Short Interest DataCurrent Short Volume3,470,000 sharesPrevious Short Volume3,540,000 sharesChange Vs. Previous Month-1.98%Dollar Volume Sold Short$386.00 millionShort Interest Ratio / Days to Cover6.5Last Record DateNovember 29, 2019Outstanding Shares38,523,000 sharesFloat Size34,800,000 sharesShort Percent of Float9.97%Today's Trading Volume0 sharesAverage Trading Volume891,560 sharesToday's Volume Vs. Average0% Short Selling Spark Therapeutics ? Sign up to receive the latest short interest report for Spark Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatONCE Short Interest Over TimeONCE Days to Cover Over TimeONCE Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Spark Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/29/20193,470,000 shares $386.00 million -2.0%10.0%6.5 $111.24 ONCE Short Interest - Frequently Asked Questions What is Spark Therapeutics' current short interest? Short interest is the volume of Spark Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 29th, traders have sold 3,470,000 shares of ONCE short. 9.97% of Spark Therapeutics' shares are currently sold short. Learn More on Spark Therapeutics' current short interest. What is a good short interest ratio for Spark Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONCE shares currently have a short interest ratio of 6.0. Learn More on Spark Therapeutics's short interest ratio. What is a good short interest percentage for Spark Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.97% of Spark Therapeutics' floating shares are currently sold short. Is Spark Therapeutics' short interest increasing or decreasing? Spark Therapeutics saw a decline in short interest in November. As of November 29th, there was short interest totaling 3,470,000 shares, a decline of 2.0% from the previous total of 3,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Spark Therapeutics' float size? Spark Therapeutics currently has issued a total of 38,523,000 shares. Some of Spark Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Spark Therapeutics currently has a public float of 34,800,000 shares. How does Spark Therapeutics' short interest compare to its competitors? 9.97% of Spark Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Spark Therapeutics: Titan Pharmaceuticals, Inc. (0.59%), Creative Medical Technology Holdings, Inc. (2.17%), Fresh Tracks Therapeutics, Inc. (0.17%), Palisade Bio, Inc. (0.21%), Genetic Technologies Limited (0.30%), Finch Therapeutics Group, Inc. (1.70%), TRACON Pharmaceuticals, Inc. (32.74%), Organovo Holdings, Inc. (1.61%), BioCardia, Inc. (1.99%), Avalon GloboCare Corp. (1.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Slack Technologies, Inc. ($887.06 million), CrowdStrike Holdings, Inc. ($441.98 million), Spark Therapeutics Inc ($386.00 million), Carrizo Oil & Gas, Inc. ($169.28 million), Rocket Pharmaceuticals, Inc. ($153.59 million), CEL-SCI Co. ($51.42 million), Presidio Inc ($39.72 million), Vitamin Shoppe Inc ($22.16 million), Anavex Life Sciences Corp. ($14.63 million), and Affimed ($11.43 million). View all of the most shorted stocks. What does it mean to sell short Spark Therapeutics stock? Short selling ONCE is an investing strategy that aims to generate trading profit from Spark Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spark Therapeutics? A short squeeze for Spark Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ONCE, which in turn drives the price of the stock up even further. How often is Spark Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONCE, twice per month. The most recent reporting period available is November, 29 2019. More Short Interest Resources from MarketBeat Related Companies: TTNP Short Interest Data CELZ Short Interest Data FRTX Short Interest Data PALI Short Interest Data GENE Short Interest Data FNCH Short Interest Data TCON Short Interest Data ONVO Short Interest Data BCDA Short Interest Data ALBT Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ONCE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders